All AbMole products are for research use only, cannot be used for human consumption.
Aminoglutethimide (Cytadren) is an inhibitor of adrenocortical steroid synthesis. It blocks aromatase in the generation of estrogens from androstenedione and testosterone. It also blocks the conversion of cholesterol to pregnenolone by inhibiting the enzyme P450scc and consequently decreases synthesis of all hormonally active steroids. It inhibited bovine adrenal cholesterol side-chain cleavage activity with an IC50 value of 40 μM.
| Cell Experiment | |
|---|---|
| Cell lines | Adrenocortical tumor cell line NCI-h295 |
| Preparation method | Maintaining the NCI-h295 tumor cell line in RPMI 1640 medium which is supplemented with transferrin (0.1 mg/mL), insulin (5 μg/mL), selenium (5.2 μg/mL) and 2% FCS. Incubating the cells for 48 hours with Aminoglutethimide (3, 30, 300 μM). Then examining cells by trypan blue staining for cell viability, counting with a coulter counter. For the assessment of ACTH-R mRNA, cells are harvested, and total RNA is extracted, electrophoresed, blotted and hybridized with a human ACTH-R cDNA probe. |
| Concentrations | Dissolved in 65% ethanol as a stock solution, final concentrations 3, 30, 300 μM. |
| Incubation time | 48 hours |
| Animal Experiment | |
|---|---|
| Animal models | Swiss CD1 male and female mice |
| Formulation | Dissolved in DMSO and diluted in saline. |
| Dosages | 150 mg/kg |
| Administration | Injection |
| Molecular Weight | 232.28 |
| Formula | C13H16N2O2 |
| CAS Number | 125-84-8 |
| Solubility (25°C) | DMSO 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] G Cocconi. First generation aromatase inhibitors--aminoglutethimide and testololactone
[2] R J Santen, et al. Aminoglutethimide: review of pharmacology and clinical use
[3] No authors listed. Lancet. Aminoglutethimide
[4] S W Hughss, et al. Aminoglutethimide: a "side-effect" turned to therapeutic advantage
| Related Products |
|---|
| 2-Bromo-4-chlorophenylacetic acid
2-Bromo-4-chlorophenylacetic acid is a biochemical reagent. |
| CPN-351 TFA
CPN-351 TFA is a selective pentapeptide antagonist of human NMUR1 with a pA2 of 7.35. CPN-351 TFA can be used for the research of inflammation. |
| 5-Phenyluracil
5-Phenyluracil is a pyrimidine derivative, a class of heterocyclic aromatic organic compounds crucial in biochemistry. It serves as a synthetic nucleoside analogue, meaning it mimics the structure of naturally occurring nucleosides like uridine. This structural similarity allows it to participate in biochemical reactions, often interfering with normal cellular processes, making it a valuable tool in studying nucleic acid metabolism and developing antiviral and anticancer agents. |
| 7-Deoxyloganin
7-Deoxyloganin is a biosynthetic precursor of Loganin. 7-Deoxyloganin undergoes hydroxylation catalyzed by 7-deoxyloganin 7-hydroxylase, a cytochrome P450-dependent monooxygenase, to produce Loganin. |
| Mannose-BSA
Mannose-BSA is an important organic intermediate that combines the properties of mannose and bovine serum albumin, which is of unique value in the field of scientific research, and can be used as a key substance in a variety of organic synthesis reactions. Mannose is an important monosaccharide that binds specifically to mannose receptors (e.g., CD206 receptors on dendritic cells and macrophages), and therefore has a wide range of applications in immunomodulation and targeted drug delivery. BSA is a protein carrier that is commonly used for biocoupling, and its abundant surface amino groups can covalently bind to mannose to form a mannose-BSA complex. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
